Advertisement

Intrahepatic Cholangiocarcinoma

  • Maxime Ronot
  • Valérie Vilgrain
Chapter
Part of the Cancer Dissemination Pathways book series (CDP)

Abstract

The diagnosis of intrahepatic cholangiocarcinoma is based on pathology. Nevertheless, imaging plays a central role for tumor staging as well as for the assessment of locoregional and distant extension. Tumor spread is very different from that in other liver tumors, especially hepatocellular carcinoma. Parenchymal, vascular, perineural, nodal, and distant extension must be accurately assessed because it has significant prognostic value. Computerized tomography (CT) and magnetic resonance imaging (MRI) provide essential information, while positron emission tomography (PET) can be useful in selected cases.

Notes

Conflict of Interests

None of the authors have any conflict of interest or financial ties to disclose.

References

  1. 1.
    Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T et al (2014) Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 60(6):1268–1289CrossRefPubMedGoogle Scholar
  2. 2.
    The general rules for the clinical and pathological study of primary liver cancer. Liver cancer study group of Japan. Jpn J Surg 1989;19(1):98–129Google Scholar
  3. 3.
    Pupulim LF, Vilgrain V, Ronot M, Becker CD, Breguet R, Terraz S (2015) Hepatic lymphatics: anatomy and related diseases. Abdom Imaging 40(6):1997–2011CrossRefPubMedGoogle Scholar
  4. 4.
    Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM (2014) Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg 149(6):565–574CrossRefPubMedGoogle Scholar
  5. 5.
    Shirai K, Ebata T, Oda K, Nishio H, Nagasaka T, Nimura Y et al (2008) Perineural invasion is a prognostic factor in intrahepatic cholangiocarcinoma. World J Surg 32(11):2395–2402CrossRefPubMedGoogle Scholar
  6. 6.
    Liebig C, Ayala G, Wilks JA, Berger DH, Albo D (2009) Perineural invasion in cancer: a review of the literature. Cancer 115(15):3379–3391CrossRefPubMedGoogle Scholar
  7. 7.
    Kurzawinski TR, Deery A, Dooley JS, Dick R, Hobbs KE, Davidson BR (1993) A prospective study of biliary cytology in 100 patients with bile duct strictures. Hepatology 18(6):1399–1403CrossRefPubMedGoogle Scholar
  8. 8.
    Okabayashi T, Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Takayama T et al (2001) A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 92(9):2374–2383CrossRefPubMedGoogle Scholar
  9. 9.
    Yamasaki S (2003) Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. J Hepato-Biliary-Pancreat Surg 10(4):288–291CrossRefGoogle Scholar
  10. 10.
    Nathan H, Aloia TA, Vauthey JN, Abdalla EK, Zhu AX, Schulick RD et al (2009) A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 16(1):14–22CrossRefPubMedGoogle Scholar
  11. 11.
    Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471–1474CrossRefPubMedGoogle Scholar
  12. 12.
    Farges O, Fuks D, Le Treut YP, Azoulay D, Laurent A, Bachellier P et al (2011) AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the AFC-IHCC-2009 Study Group. Cancer 117(10):2170–2177CrossRefPubMedGoogle Scholar
  13. 13.
    Kim Y, Spolverato G, Amini N, Margonis GA, Gupta R, Ejaz A et al (2015) Surgical management of intrahepatic cholangiocarcinoma: defining an optimal prognostic lymph node stratification schema. Ann Surg Oncol 22(8):2772–2778CrossRefPubMedGoogle Scholar
  14. 14.
    Sakamoto Y, Kokudo N, Matsuyama Y, Sakamoto M, Izumi N, Kadoya M et al (2016) Proposal of a new staging system for intrahepatic cholangiocarcinoma: analysis of surgical patients from a nationwide survey of the Liver Cancer Study Group of Japan. Cancer 122(1):61–70CrossRefPubMedGoogle Scholar
  15. 15.
    Hann LE, Schwartz LH, Panicek DM, Bach AM, Fong Y, Blumgart LH (1998) Tumor involvement in hepatic veins: comparison of MR imaging and US for preoperative assessment. Radiology 206(3):651–656CrossRefPubMedGoogle Scholar
  16. 16.
    Hwang S, Lee YJ, Song GW, Park KM, Kim KH, Ahn CS et al (2015) Prognostic impact of tumor growth type on 7th AJCC staging system for intrahepatic cholangiocarcinoma: a single-center experience of 659 cases. J Gastrointest Surg 19(7):1291–1304CrossRefPubMedGoogle Scholar
  17. 17.
    Zhang Y, Uchida M, Abe T, Nishimura H, Hayabuchi N, Nakashima Y (1999) Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI. J Comput Assist Tomogr 23(5):670–677CrossRefPubMedGoogle Scholar
  18. 18.
    Madoff DC, Hicks ME, Abdalla EK, Morris JS, Vauthey JN (2003) Portal vein embolization with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy: safety and effectiveness—study in 26 patients. Radiology 227(1):251–260CrossRefPubMedGoogle Scholar
  19. 19.
    Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K et al (1997) Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 26(5):1176–1181PubMedGoogle Scholar
  20. 20.
    Vilgrain V (2008) Staging cholangiocarcinoma by imaging studies. HPB (Oxford) 10(2):106–109CrossRefGoogle Scholar
  21. 21.
    Kang Y, Lee JM, Kim SH, Han JK, Choi BI (2012) Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. Radiology 264(3):751–760CrossRefPubMedGoogle Scholar
  22. 22.
    Vilgrain V, Van Beers BE, Flejou JF, Belghiti J, Delos M, Gautier AL et al (1997) Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients. J Comput Assist Tomogr 21(1):59–65CrossRefPubMedGoogle Scholar
  23. 23.
    Feydy A, Vilgrain V, Denys A, Sibert A, Belghiti J, Vullierme MP et al (1999) Helical CT assessment in hilar cholangiocarcinoma: correlation with surgical and pathologic findings. AJR Am J Roentgenol 172(1):73–77CrossRefPubMedGoogle Scholar
  24. 24.
    Bach AM, Hann LE, Brown KT, Getrajdman GI, Herman SK, Fong Y et al (1996) Portal vein evaluation with US: comparison to angiography combined with CT arterial portography. Radiology 201(1):149–154CrossRefPubMedGoogle Scholar
  25. 25.
    Uchida M, Ishibashi M, Tomita N, Shinagawa M, Hayabuchi N, Okuda K (2005) Hilar and suprapancreatic cholangiocarcinoma: value of 3D angiography and multiphase fusion images using MDCT. AJR Am J Roentgenol 184(5):1572–1577CrossRefPubMedGoogle Scholar
  26. 26.
    Farges O, Fuks D, Boleslawski E, Le Treut YP, Castaing D, Laurent A et al (2011) Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group. Ann Surg 254(5):824–829, discussion 30CrossRefPubMedGoogle Scholar
  27. 27.
    Adachi T, Eguchi S, Beppu T, Ueno S, Shiraishi M, Okuda K et al (2015) Prognostic impact of preoperative lymph node enlargement in intrahepatic cholangiocarcinoma: a multi-institutional study by the Kyushu Study Group of Liver Surgery. Ann Surg Oncol 22(7):2269–2278CrossRefPubMedGoogle Scholar
  28. 28.
    Okami J, Dono K, Sakon M, Tsujie M, Hayashi N, Fujiwara Y et al (2003) Patterns of regional lymph node involvement in intrahepatic cholangiocarcinoma of the left lobe. J Gastrointest Surg 7(7):850–856CrossRefPubMedGoogle Scholar
  29. 29.
    Lee SW, Kim HJ, Park JH, Park DI, Cho YK, Sohn CI et al (2010) Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma. J Gastroenterol 45(5):560–566CrossRefPubMedGoogle Scholar
  30. 30.
    Shen FZ, Zhang BY, Feng YJ, Jia ZX, An B, Liu CC et al (2010) Current research in perineural invasion of cholangiocarcinoma. J Exp Clin Cancer Res 29:24CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Murakawa K, Tada M, Takada M, Tamoto E, Shindoh G, Teramoto K et al (2004) Prediction of lymph node metastasis and perineural invasion of biliary tract cancer by selected features from cDNA array data. J Surg Res 122(2):184–194CrossRefPubMedGoogle Scholar
  32. 32.
    Maxwell P, Hamilton PW, Sloan JM (1996) Three-dimensional reconstruction of perineural invasion in carcinoma of the extrahepatic bile ducts. J Pathol 180(2):142–145Google Scholar
  33. 33.
    Raghavan K, Jeffrey RB, Patel BN, DiMaio MA, Willmann JK, Olcott EW (2015) MDCT diagnosis of perineural invasion involving the celiac plexus in intrahepatic cholangiocarcinoma: preliminary observations and clinical implications. AJR Am J Roentgenol 205(6):W578–W584CrossRefPubMedGoogle Scholar
  34. 34.
    Anderson CD, Rice MH, Pinson CW, Chapman WC, Chari RS, Delbeke D (2004) Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 8(1):90–97CrossRefPubMedGoogle Scholar
  35. 35.
    Corvera CU, Blumgart LH, Akhurst T, DeMatteo RP, D’Angelica M, Fong Y et al (2008) 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer. J Am Coll Surg 206(1):57–65CrossRefPubMedGoogle Scholar
  36. 36.
    Kim YJ, Yun M, Lee WJ, Kim KS, Lee JD (2003) Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging 30(11):1467–1472CrossRefPubMedGoogle Scholar
  37. 37.
    Baheti AD, Tirumani SH, Shinagare AB, Rosenthal MH, Hornick JL, Ramaiya NH et al (2014) Correlation of CT patterns of primary intrahepatic cholangiocarcinoma at the time of presentation with the metastatic spread and clinical outcomes: retrospective study of 92 patients. Abdom Imaging 39(6):1193–1201CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of RadiologyUniversity Hospitals Paris Nord Val de SeineClichy (Hauts-de-Seine)France
  2. 2.University Paris DiderotParisFrance
  3. 3.INSERM U1149Centre de recherche biomédicale Bichat-BeaujonParisFrance

Personalised recommendations